Discriminant function analysis of body surface potential maps in acute myocardial infarction.

Using a newly developed 64-electrode portable mapping device, QRS and ST-T isointegral maps were compared in 194 control subjects and 101 patients. One hundred ninety-four control subjects (mean age, 48 years; 120 men) with no history of cardiac disease were selected randomly and mapped. One hundred one patients (mean age, 62 years; 77 men) were mapped at presentation of chest pain suggestive of first myocardial infarction (MI); all patients had classic 12-lead electrocardiographic findings--46 with anterior and 55 with inferior MI. The diagnosis was confirmed in all cases by a significant rise in serial cardiac enzymes. The mean delay between onset of chest pain to map recording was 163 minutes. Of the 101 patients, 78 were first mapped outside the hospital. Applying discriminant function analysis to the isointegral measurements made on the control subjects and on the first map of MI patients achieved a correct classification of 97% of the control subjects (189 of 194) and 72% of the anterior (33 of 46) and 76% of the inferior (42 of 55) MI groups. This preliminary study suggests that discriminant function analysis, based on isointegral maps, not only provides a method of separating control subjects from MI patients but that it can also differentiate between types of infarct. Further studies are required to improve the predictive values of discriminant function and to extend the methodology to assess both the site and size of MI.

[1]  Brian D. Ripley,et al.  Neural Networks and Related Methods for Classification , 1994 .

[2]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[3]  P M Rautaharju,et al.  Body Surface Potential Mapping of ST Segment Changes in Acute Myocardial Infarction Implications for ECG Enrollment Criteria for Thrombolytic Therapy , 1993, Circulation.

[4]  W. O’Neill,et al.  Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy. , 1991, Annals of internal medicine.

[5]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[6]  S. Goldstein,et al.  Ventricular remodelling: consequences and therapy. , 1993, European heart journal.

[7]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[8]  E. Topol,et al.  Selection of patients with acute myocardial infarction for thrombolytic therapy. , 1990, Annals of internal medicine.

[9]  R. Leinbach Thrombolysis in unstable angina. , 1992, Circulation.

[10]  R. Wilson,et al.  Thrombolysis in Unstable Angina: Randomized Double‐Blind Trial of t‐PA and Placebo , 1992, Circulation.

[11]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[12]  C. Grines,et al.  Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. , 1990, Journal of the American College of Cardiology.

[13]  P. Serruys,et al.  Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? , 1986, Circulation.

[14]  S C Hunt,et al.  Effects of age, sex, and body habitus on QRS and ST-T potential maps of 1100 normal subjects. , 1985, Circulation.

[15]  K. Ikeda,et al.  Determination of the site of myocardial infarction by QRST isointegral mapping in patients with abnormal ventricular activation sequence. , 1987, Japanese heart journal.